Corcept Therapeutics Incorporated shares owned by Guggenheim Capital, LLC Managers
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Guggenheim Capital, LLC Managers
from 13F filings
Historical chart of Guggenheim Capital, LLC Managers investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Guggenheim Capital, LLC Managers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Guggenheim Capital, LLC Managers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $205k | 6.5k | 31.38 |
| 2023-06-30 | $443k | 20k | 22.25 |
| 2023-03-31 | $704k | 33k | 21.66 |
| 2022-12-31 | $382k | 19k | 20.31 |
| 2022-09-30 | $554k | 22k | 25.58 |
| 2022-06-30 | $523k | 22k | 23.75 |
| 2022-03-31 | $551k | 24k | 22.98 |
| 2021-12-31 | $435k | 22k | 19.92 |
| 2021-09-30 | $1.3M | 64k | 19.69 |
| 2021-06-30 | $498k | 23k | 21.99 |
| 2021-03-31 | $575k | 24k | 23.79 |
| 2020-12-31 | $1.2M | 45k | 26.16 |
| 2020-09-30 | $179k | 10k | 17.42 |
| 2020-06-30 | $261k | 16k | 16.81 |
| 2019-12-31 | $210k | 17k | 12.13 |
| 2019-09-30 | $234k | 17k | 14.13 |
| 2019-06-30 | $241k | 22k | 11.10 |
| 2019-03-31 | $405k | 35k | 11.73 |
| 2018-12-31 | $637k | 48k | 13.35 |
| 2018-09-30 | $1.5M | 107k | 14.01 |
| 2018-06-30 | $1.4M | 89k | 15.74 |
| 2018-03-31 | $3.9M | 239k | 16.44 |
| 2017-12-31 | $3.8M | 211k | 18.06 |
| 2017-03-31 | $211k | 19k | 10.86 |
| 2016-12-31 | $194k | 27k | 7.29 |
| 2016-09-30 | $179k | 28k | 6.31 |
| 2016-06-30 | $163k | 30k | 5.48 |
| 2016-03-31 | $123k | 28k | 4.36 |
| 2011-09-30 | $105k | 34k | 3.09 |
| 2011-06-30 | $207k | 49k | 4.27 |
| 2011-03-31 | $217k | 52k | 4.14 |
More positions owned by Guggenheim Capital, LLC Managers
View all positions for Guggenheim Capital, LLC Managers
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated